Midazolam Base
Midazolam Base Brand names, Midazolam Base Analogs
Midazolam Base Brand Names Mixture
- No information avaliable
Midazolam Base Chemical_Formula
C18H13ClFN3
Midazolam Base RX_link
http://www.rxlist.com/cgi/generic2/versedsyr.htm
Midazolam Base fda sheet
Midazolam Base msds (material safety sheet)
Midazolam Base Synthesis Reference
No information avaliable
Midazolam Base Molecular Weight
325.767 g/mol
Midazolam Base Melting Point
159 oC
Midazolam Base H2O Solubility
40.0 mg/ml
Midazolam Base State
Solid
Midazolam Base LogP
3.868
Midazolam Base Dosage Forms
Liquid; Solution
Midazolam Base Indication
For use in pediatric patients for sedation, anxiolysis, and amnesia prior to diagnostic, therapeutic, or endoscopic procedures or before induction of anesthesia.
Midazolam Base Pharmacology
Midazolam is a short-acting benzodiazepine central nervous system (CNS) depressant. Pharmacodynamic properties of midazolam and its metabolites, which are similar to those of other benzodiazepines, include sedative, anxiolytic, amnesic and hypnotic activities. Benzodiazepine pharmacologic effects appear to result from reversible interactions with the (gamma)-amino butyric acid (GABA) benzodiazepine receptor in the CNS, the major inhibitory neurotransmitter in the central nervous system. The action of midazolam is readily reversed by the benzodiazepine receptor antagonist, flumazenil.
Midazolam Base Absorption
Rapidly absorbed after oral administration (absolute bioavailability of the midazolam syrup in pediatric patients is about 36%, and intramuscular is greater than 90%).
Midazolam Base side effects and Toxicity
LD50=825 mg/kg (Orally in rats). Signs of overdose include sedation, somnolence, confusion, impaired coordination, diminished reflexes, coma, and deleterious effects on vital signs.
Midazolam Base Patient Information
Midazolam Base Organisms Affected
Humans and other mammals
